Jacques Izopet to Organ Transplantation
This is a "connection" page, showing publications Jacques Izopet has written about Organ Transplantation.
Connection Strength
0.738
-
Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France. Emerg Infect Dis. 2017 02; 23(2):353-356.
Score: 0.224
-
Ribavirin for chronic hepatitis E virus infection. N Engl J Med. 2014 06 19; 370(25):2447-8.
Score: 0.187
-
Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients. Transplantation. 2021 10 01; 105(10):e146-e147.
Score: 0.078
-
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients. Am J Transplant. 2022 01; 22(1):322-323.
Score: 0.077
-
Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation. Kidney Int. 2021 10; 100(4):915-927.
Score: 0.076
-
Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. J Hepatol. 2019 01; 70(1):206-209.
Score: 0.063
-
Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses. 2019 07 09; 11(7).
Score: 0.017
-
Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 06; 21(3):e13065.
Score: 0.016